Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

High-risk Leukemias 1

Interventions

pembrolizumab 223 Cyclophosphamide 192 Radiotherapy 183 Nivolumab 181 Carboplatin 153 Cisplatin 114 Paclitaxel 112 Dexamethasone 110 Radiosurgery 103 Magnetic Resonance Spectroscopy 97 Surveys and Questionnaires 90 Ipilimumab 81 Doxorubicin 79 Lenalidomide 76 Rituximab 75 durvalumab 74 atezolizumab 72 Radiation 72 fludarabine 68 Standard of Care 68 Gemcitabine 68 venetoclax 67 Specimen Handling 65 Etoposide 64 Capecitabine 64 Bevacizumab 62 Oxaliplatin 59 Docetaxel 58 Biopsy 58 Radiotherapy, Intensity-Modulated 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER × Interleukin-15 × Clear all

NCT05304754 2025-04-06

PHINK

Instituto de Investigación Hospital Universitario La Paz

Phase 1/2 Active not recruiting

Other hematologic neoplasm

High-risk Leukemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡